Schedule

26 September 2024

8:30 – 9:00

9:00 – 9:10

Alejandro Piris, Chief Scientific Officer, VHIO

9.10 – 10:00

The Long (and bumpy) Journey to Develop a Clinically Viable MYC Inhibitor

Laura Soucek, VHIO / PEPTOMYC

10:00 – 11:00

Genetics, Epigenetics and Molecular Bases of Disease

11:00 – 11:20

11:20 – 11:35

Fostering a strong R&D ecosystem

11:35 – 13:05

New approach to oncological research

13:05 – 13:55

14:00 – 15:00

Stem cells and Modeling

15:00 – 16:00

Perspectives from Industry: Spin-offs, Start-ups, & Tech Transfer

Júlia Domingo/ ALLOX, Ana Portela/ Xenopat, Andre Guedes/ Flomics,
Alejo Chorny/ AdBio, & Avencia Sanchez-Mejias Garcia/ Integra Therapeutics

16:00 – 16.20

16:20 – 17:50

'Reflective Development' by Kintsugi Coaching

17:50 – 18:00

Organising Team

Page updated

Google Sites

Report abuse